CUAMC
TBPH icon

China Universal Asset Management Company’s Theravance Biopharma TBPH Stock Holding History

China Universal Asset Management Company’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139K Sell
8,205
-787
-9% -$13K 0.01% 387
2026
Q1 		$146K Buy
8,992
+735
+9% +$13K 0.01% 377
2025
Q4 		$154K Sell
8,257
-571
-6% -$9.47K 0.01% 371
2025
Q3 		$129K Sell
8,828
-1,215
-12% -$15.4K 0.01% 368
2025
Q2 		$111K Buy
10,043
+179
+2% +$1.74K 0.01% 360
2025
Q1 		$88.1K Sell
9,864
-563
-5% -$5.24K 0.01% 366
2024
Q4 		$98.1K Buy
10,427
+1,018
+11% +$9.26K 0.01% 393
2024
Q3 		$75.8K Buy
9,409
+3,696
+65% +$32K 0.01% 373
2024
Q2 		$48.4K Sell
5,713
-3,870
-40% -$34.9K 0.01% 358
2024
Q1 		$86K Buy
9,583
+3,824
+66% +$35.4K 0.01% 385
2023
Q4 		$64.7K Buy
5,759
+4,402
+324% +$44.3K 0.01% 341
2023
Q3 		$11.7K Buy
1,357
+600
+79% +$5.79K ﹤0.01% 338
2023
Q2 		$7.83K Sell
757
-156
-17% -$1.72K ﹤0.01% 334
2023
Q1 		$9.91K Buy
913
+229
+33% +$2.42K ﹤0.01% 295
2022
Q4 		$7.67K Sell
684
-32
-4% -$336 ﹤0.01% 251
2022
Q3 		$7K Buy
+716
New +$6.71K ﹤0.01% 239

Other funds holding TBPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

China Universal Asset Management Company's TBPH Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Theravance Biopharma (TBPH) stake by 8.8% in Q2 2026, selling an estimated $13K and leaving 8,205 shares worth $139K. The position accounts for 0.01% of the portfolio, ranked #387.

China Universal Asset Management Company first reported a position in TBPH in Q3 2022 and has held it in 16 quarters since. The position peaked at $154K in Q4 2025. 91 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • China Universal Asset Management Company held 8,205 shares of Theravance Biopharma worth $139K as of Q2 2026.
  • China Universal Asset Management Company sold 787 Theravance Biopharma shares in Q2 2026, an estimated $13K.
  • Theravance Biopharma made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #387 holding.
  • China Universal Asset Management Company first reported a position in Theravance Biopharma in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Theravance Biopharma position peaked at $154K in Q4 2025.
  • 91 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.